Choroidal Thickness Association With Primary Angle Closure

Choroidal Thickness Clinical Trial

Official title:

Choroidal Thickness Association With Primary Angle Closure

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03050073
• Other study ID #: IRIS
• Status: Completed
• Start date: April 18, 2016
• Est. completion date: December 31, 2016

Study information

• Verified date: August 2018
• Source: Groupe Hospitalier Paris Saint Joseph
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

A chinese study shows that chinese population eyes with a primary angle closure have a greater choroidal thickness than normal eyes.The increase of choroidal thickness would be associated to this primary angle closure.

Description:

Usual ophtalmic consultation for glaucoma with primary angle closure

Recruitment information / eligibility

• Status: Completed
• Enrollment: 42
• Est. completion date: December 31, 2016
• Est. primary completion date: June 30, 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age >18 years

• Primary angle closure confirmed by gonioscopy

• interpretable images for choroidal thickness measure

• interpretable images by Ultra Bio Microscopy (UBM)

Exclusion Criteria:

• Acute crisis for angle closure

• Rethinopathy (diabetic or hypertensive)

• Histories of intra-eye surgery

• Great myopia

• Hypermetropia

• retinal pathology

Related Conditions & MeSH terms

• Choroidal Thickness

Locations

Country	Name	City	State
France	Groupe Hospitalier Paris Saint Joseph	Paris	Ile-de-France

Sponsors (1)

Lead Sponsor	Collaborator
Groupe Hospitalier Paris Saint Joseph

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	change of choroidal thickness measurement by Imaging of the fundus oculi (OCT swept source)		Day 1 Day 30